255 results on '"Advani, Pooja"'
Search Results
2. SOUND (Sentinel Node Versus Observation After Axillary Ultrasound) Trial: Are We Ready to Change the Tune of Our Breast Cancer Practice?
3. The sharks are circling: a qualitative study of living with metastatic breast cancer
4. Metastatic Non–Small Cell Lung Cancer Mimicking Metaplastic Breast Cancer: A Case Report
5. Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience
6. A retrospective, descriptive analysis of a single-center experience with patients with metaplastic breast cancer.
7. Trends over time in liquid biopsy testing in patients with metastatic breast cancer (MBC) across the Mayo Clinic enterprise.
8. Cancer treatment–specific medication beliefs among metastatic breast cancer patients: a qualitative study
9. Limiting Screening Mammography Recalls for Vaccine-Induced Adenopathy, a Single Institution Experience
10. Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients
11. Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients
12. Updates in prognostication and treatment of Waldenström’s macroglobulinemia
13. Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial
14. MRI phenotypes associated with breast cancer predisposing genetic variants, a multisite review
15. The Sharks Are Circling: A Qualitative Study of Living with Metastatic Breast Cancer
16. Abstract P4-01-22: Clinical outcomes of metastatic breast cancer patients treated with poly (adenosine diphosphate-ribose) polymerase inhibitors (PARPi): the Mayo Clinic experience
17. Abstract P3-05-25: Clinical Factors associated with Survival Outcomes in Patients with Metaplastic Breast Cancer
18. Abstract P4-01-17: Phase I/II study of pembrolizumab in combination with oral binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer
19. N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy
20. How Well Does Non-mass Enhancement Correlate With DCIS/Invasive Cancer?
21. The Estrogen Pathway: Estrogen Receptor-α, Progesterone Receptor, and Estrogen Receptor-β Expression in Radical Cystectomy Urothelial Cell Carcinoma Specimens
22. Understanding Patient Perspective, Challenges, Behavioral Patterns, and Preferences Towards Participation in Multiple Myeloma Clinical Trials: A Prospective Study
23. Medical Marijuana Use for Cancer-Related Symptoms among Floridians: A Descriptive Study
24. FES avid pulmonary adenocarcinoma and confounding ER+ breast carcinoma
25. Exploring the Biological and Physical Basis of Boron Neutron Capture Therapy (BNCT) as a Promising Treatment Frontier in Breast Cancer
26. Phase II trial to evaluate immune-related biomarkers for pathological response in stage II-III HER2-positive breast cancer receiving neoadjuvant chemotherapy with subsequent randomization to multi-epitope HER2 vaccine versus placebo in patients with residual disease post-neoadjuvant chemotherapy.
27. HSR22-126: Key Factors Associated With Breast Cancer Clinical Trial Enrollment in Underrepresented Minority Groups
28. HOME CARDIAC SURVEILLANCE WITH ARTIFICIAL INTELLIGENCE DIGITAL PATIENT MONITORING DURING TREATMENT WITH PERTUZUMAB, TRASTUZUMAB AND HYALURONIDASE-ZZXF FOR HER2-POSITIVE BREAST CANCER (HARRIET): STUDY DESIGN AND RATIONALE
29. Mo1347 PHASE II TRIAL OF RIFAXIMIN IN PATIENTS WITH EARLY-STAGE HER2 POSITIVE BREAST CANCER WITH GASTROINTESTINAL TOXICITIES RELATED TO PERTUZUMAB-BASED THERAPY
30. Abstract P2-11-15: Clinical trial enrollment for initial therapy of breast cancer: Exploring factors associated with poor accrual and significant disparities
31. Abstract P3-03-19: Incidence and time to resolution of axillary adenopathy on mammography after COVID-19 vaccination
32. Abstract P5-14-16: Factors associated with endocrine therapy refusal in hormone receptor-positive breast cancer patients
33. Abstract P3-23-01: Antibody responses after SARS-CoV-2 mRNA vaccination in breast cancer patients
34. A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy
35. Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis
36. Inter-Individual Variation and Cardioprotection in Anthracycline-Induced Heart Failure
37. Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination
38. Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells
39. Effect of health care disparities on procedure selection of autologous breast reconstruction in Florida
40. Case Report: Alpelisib-Induced Drug Reaction With Eosinophilia and Systemic Symptoms: A Rare Manifestation of a Common Side Effect
41. Abstract CT133: Results of phase I study of pembrolizumab in combination with binimetinib in patients with unresectable locally advanced or metastatic triple negative breast cancer
42. Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis
43. The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs
44. Outcome and immune landscape of HER2-positive invasive lobular carcinoma in the North Central Cancer Treatment Group (NCCTG) N9831 (Alliance) trial.
45. Awareness of myeloma care and the global impact of treatment: An international internet-based prospective study
46. HER2 testing across practices-Have we come to a consensus on the ideal method of testing? A systematic literature review
47. Abstract PS6-03: Prognostic value of clinical treatment score post-5 years (CTS5) and late relapse risk in hormone receptor-positive HER2-positive breast cancer in the North Central Cancer Treatment Group (NCCTG) N9831 (Alliance) and NSABP B-31 (NRG) trials
48. Paget disease of the breast: A national retrospective analysis of the US population
49. Awareness of myeloma care and the global impact of treatment: An international internet-based prospective study.
50. WITHDRAWN: Updates in Prognostication and Treatment of Waldenström’s Macroglobulinemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.